Neuland Laboratories Complete Financial Statements
NEULANDLAB • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Neuland Laboratories (NEULANDLAB).
Downloads include all available records across all periods.
For market performance, see the
NEULANDLAB stock price today
.
Profitability Ratios
Net Profit Margin
18.80%
2025 data
EBITDA Margin
30.43%
2025 data
Operating Margin
30.00%
2025 data
Return on Assets
4.45%
2025 data
Return on Equity
6.36%
2025 data
Balance Sheet Ratios
Current Ratio
6.03
2025 data
Debt to Equity
1.43
2025 data
Equity Ratio
69.95%
2025 data
Asset Turnover
0.24
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+63.8%
Year-over-Year
Net Profit Growth
+193.9%
Year-over-Year
EBITDA Growth
+134.3%
Year-over-Year
Expense Growth
+44.2%
Year-over-Year
Assets Growth
+18.9%
Year-over-Year
Equity Growth
+18.9%
Year-over-Year
Liabilities Growth
+18.9%
Year-over-Year
Operating Cash Flow Growth
+21.5%
Year-over-Year
Investing Cash Flow Growth
-98.7%
Year-over-Year
Financing Cash Flow Growth
+136.2%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 516 | 336 | 301 | 315 | 390 | 465 | 458 | 421 | 415 | 365 | 395 | 294 | 257 | 222 | 270 | 258 | 259 | 203 | 238 | 242 | 193 | 206 | 246 | 187 | 174 | 182 | 205 | 169 | 155 | 172 |
| Expenses | 359 | 277 | 258 | 249 | 278 | 316 | 311 | 280 | 287 | 266 | 272 | 224 | 217 | 193 | 215 | 215 | 219 | 175 | 204 | 201 | 162 | 172 | 199 | 161 | 154 | 162 | 176 | 154 | 145 | 156 |
| EBITDA | 157 | 59 | 42 | 67 | 112 | 149 | 146 | 141 | 128 | 99 | 123 | 70 | 40 | 29 | 55 | 43 | 40 | 28 | 34 | 42 | 32 | 35 | 47 | 26 | 20 | 19 | 29 | 15 | 10 | 16 |
| Operating Profit Margin % | 30.00% | 16.00% | 12.00% | 20.00% | 28.00% | 28.00% | 22.00% | 33.00% | 29.00% | 27.00% | 31.00% | 24.00% | 15.00% | 13.00% | 20.00% | 17.00% | 10.00% | 13.00% | 14.00% | 17.00% | 16.00% | 16.00% | 19.00% | 13.00% | 11.00% | 10.00% | 14.00% | 9.00% | 6.00% | 9.00% |
| Depreciation | 23 | 17 | 20 | 16 | 17 | 16 | 16 | 15 | 14 | 14 | 15 | 13 | 12 | 13 | 13 | 12 | 11 | 12 | 13 | 9 | 8 | 9 | 10 | 8 | 7 | 8 | 8 | 6 | 6 | 7 |
| Interest | 5 | 2 | 5 | 1 | 4 | 3 | 2 | 4 | 4 | 2 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 4 | 7 | 5 | 4 | 5 | 5 | 4 | 6 | 4 | 4 | 3 |
| Profit Before Tax | 129 | 39 | 18 | 49 | 92 | 130 | 128 | 122 | 110 | 83 | 105 | 53 | 24 | 14 | 39 | 28 | 24 | 12 | 18 | 29 | 17 | 20 | 32 | 12 | 8 | 8 | 16 | 5 | 1 | 6 |
| Tax | 33 | 12 | 4 | 17 | 25 | 32 | 26 | 32 | 26 | 21 | 23 | 15 | 3 | 4 | 8 | 7 | 7 | 3 | 5 | 7 | 27 | 5 | 5 | 4 | 2 | 2 | 5 | 1 | 0 | 1 |
| Net Profit | 97 | 28 | 14 | 33 | 68 | 98 | 102 | 89 | 85 | 62 | 81 | 39 | 22 | 10 | 31 | 20 | 17 | 9 | 13 | 21 | -9 | 15 | 27 | 9 | 7 | 6 | 11 | 5 | 1 | 5 |
| Earnings Per Share (₹) | 75.49 | 21.67 | 10.83 | 25.60 | 52.66 | 76.28 | 79.18 | 69.56 | 65.90 | 48.23 | 63.44 | 29.97 | 16.97 | 7.77 | 23.81 | 15.88 | 13.48 | 6.81 | 10.08 | 16.71 | -7.25 | 11.82 | 20.84 | 6.77 | 5.17 | 4.45 | 8.66 | 3.55 | 0.44 | 3.66 |
Related Pages for Neuland Laboratories
Additional stock information and data for NEULANDLAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 2,180 | 1,833 | 1,580 | 1,384 | 1,325 | 1,231 | 1,130 | 1,071 | 886 | 524 | 512 |
| Current Assets | 1,140 | 921 | 761 | 581 | 550 | 515 | 454 | 447 | 375 | 314 | 316 |
| Fixed Assets | 955 | 824 | 758 | 767 | 716 | 653 | 542 | 475 | 466 | 139 | 123 |
| Capital Work in Progress | 48 | 46 | 41 | 21 | 17 | 24 | 105 | 126 | 20 | 41 | 42 |
| Investments | 109 | 1 | 1 | 4 | 7 | 8 | 8 | 8 | 8 | 0 | 0 |
| Other Assets | 1,068 | 962 | 781 | 592 | 585 | 547 | 477 | 463 | 393 | 345 | 347 |
| LIABILITIES | |||||||||||
| Total Liabilities | 2,180 | 1,833 | 1,580 | 1,384 | 1,325 | 1,231 | 1,130 | 1,071 | 886 | 524 | 512 |
| Current Liabilities | 189 | 122 | 147 | 180 | 170 | 163 | 104 | 146 | 54 | 69 | 55 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 1,525 | 1,283 | 994 | 841 | 787 | 710 | 699 | 558 | 546 | 187 | 162 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 1,512 | 1,270 | 981 | 828 | 774 | 697 | 686 | 549 | 537 | 178 | 152 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 317 | 261 | 237 | 60 | 189 | 57 | 70 | 11 | 39 | 45 | 13 |
| Investing Activities | -298 | -150 | -61 | -95 | -85 | -49 | -77 | -116 | -42 | -20 | -14 |
| Financing Activities | 25 | -69 | -136 | 38 | -114 | -6 | 12 | 105 | 0 | -24 | 1 |
| Net Cash Flow | 44 | 42 | 40 | 3 | -9 | 3 | 5 | 0 | -4 | 1 | 0 |